Clovis Oncology, Inc.
5500 Flatiron Parkway, Suite 100
Boulder, CO 80301
July 8, 2019
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, DC 20549
Attn: Jeff Gabor
Re: Clovis Oncology, Inc.—Request for Acceleration
Registration Statement on FormS-3
(FileNo. 333-232503)
Ladies and Gentlemen:
Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, Clovis Oncology, Inc. (the “Registrant”) hereby respectfully requests that the effectiveness of the above-captioned Registration Statement on FormS-3 (the “Registration Statement”) be accelerated to July 10, 2019 at 5:30 P.M. Eastern Time or as soon as practicable thereafter.
The cooperation of the staff in meeting the timetable described above is very much appreciated.
Sincerely,
Clovis Oncology, Inc.
| By: | /s/ Paul Gross | |
Name: Paul Gross | ||
Title: Executive Vice President, General Counsel and Chief Compliance Officer | ||
cc: Thomas Mark, Esq., Willkie Farr & Gallagher LLP
